surpass cvot tirzepatide 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What Facebook and TikTok slammed Hydration Bundle:2 months supply

surpass cvot tirzepatide 💡 New insight in diabetes care: In patients with T2DM and ASCVD, the SURPASS-CVOT trial found that was noninferior to dulaglutide for major cardiovascular events (12.2% vs 13.1%; HR 0.92). What Facebook and TikTok slammed Hydration Bundle:2 months supply

Facebook and TikTok slammed for failing to crack down on fake Ozempic jabs being sold online

doi: 10.1016/j.bios.2024.116298

Hydration

Bundle:2 months supply

Phase 2 trials showed 24.2% average body weight reduction at the 12 mg dose over 48 weeks, and the more recent Phase 3 TRIUMPH-4 trial pushed that figure up to 28.7% over 68 weeks, translating to an average loss of about 71 pounds